Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
2/26/2015
Stemline to Present at the Cowen and Company 35th Annual Health Care Conference
2/4/2015
Stemline to Present at the 17th Annual BIO CEO & Investor Conference
1/30/2015
Stemline Announces SL-701 Granted Orphan Drug Designation
Copyright 2015 - Stemline Therapeutics, Inc. All rights reserved
Stemline